FDA To Review Negative Impacts Of Anemia Drugs

The medications include Johnson & Johnson's Procrit, and Amgen's Epogen and Aranesp.

The clinical trial from 2004 involved diabetic and kidney disease patients
taking Aranesp. Those who took the drug were no more likely to die than those on a placebo, but had about double the rates of stroke.

Anemia drugs are used for patients with conditions such as chronic kidney disease and people undergoing chemotherapy, etc.

Comments are posted from viewers like you and do not always reflect the views of this station.
powered by Disqus

275 E. Arlington Blvd. Greenville, NC 27858 252-439-7777
Copyright © 2002-2016 - Designed by Gray Digital Media - Powered by Clickability 80981312 - witn.com/a?a=80981312
Gray Television, Inc.